Chronic Obstructive Pulmonary Disease (COPD) is a lung disease associated with shortness of breath and coughing due to poor airflow in the lungs. COPD is a progressive disease that ultimately limits the physical activities of those who suffer from it. Multiple factors contribute to COPD, including smoking, air pollution, and exposure to airborne irritants.
High-quality samples are paramount in developing new treatments for COPD. HemaCare sources, isolates, and ships human samples under rigorously controlled protocols to provide the optimum starting material for your research.
Patients diagnosed with COPD are recruited as donors for research products. They review and sign an independent biomedical review board (IRB) approved procedure-specific consent form prior to the collection.
Storage at -80° C is acceptable.
Testing: Donors are tested for HBV, HCV, and HIV, unless requested otherwise.